Our Pioneering Specialty

Innovating beyond limits, we craft exceptional solutions with
creativity and precision.

STAP-Test

The Screening Test for Autoimmune Polyendocrinopathies (STAP-Test) is designed to identify individuals at risk for autoimmune disorders affecting multiple endocrine glands. This test plays a crucial role in detecting early markers of endocrine dysfunction, enabling timely intervention and treatment.

IAP

The Screening Test for Autoimmune Polyendocrinopathies (STAP-Test) is designed to identify individuals at risk for autoimmune disorders affecting multiple endocrine glands. This test plays a crucial role in detecting early markers of endocrine dysfunction, enabling timely intervention and treatment.

Incipient Diabetes

Incipient diabetes, also known as early-stage diabetes, refers to the initial phase where glucose metabolism becomes abnormal but hasn’t yet progressed to full-blown diabetes. This phase is critical for preventive care and delaying the onset of Type 2 Diabetes.

Early Diagnosis of T2DM

Early diagnosis of Type 2 Diabetes Mellitus (T2DM) is vital for preventing complications associated with high blood sugar levels. Detecting diabetes in its early stages allows for lifestyle changes and treatment interventions that can significantly improve long-term health outcomes.

IAPD

Impaired Adipose Processing in Diabetes (IAPD) highlights how the dysfunctional processing of fat in adipose tissue can exacerbate insulin resistance in diabetic patients. This condition is increasingly recognized for its role in worsening the metabolic challenges faced by those with Type 2 Diabetes.